Gene silencing in mammalian cells with light-activated antisense agents - PubMed (original) (raw)

. 2008 Dec 15;9(18):2937-40.

doi: 10.1002/cbic.200800627.

Affiliations

• PMID: 19021142
• DOI: 10.1002/cbic.200800627

Gene silencing in mammalian cells with light-activated antisense agents

Douglas D Young et al. Chembiochem. 2008.

No abstract available

PubMed Disclaimer

Similar articles

• Stepwise synthesis of oligonucleotide-peptide conjugates containing guanidinium and lipophilic groups in their 3'-termini.
  Grijalvo S, Terrazas M, Aviñó A, Eritja R. Grijalvo S, et al. Bioorg Med Chem Lett. 2010 Apr 1;20(7):2144-7. doi: 10.1016/j.bmcl.2010.02.049. Epub 2010 Feb 14. Bioorg Med Chem Lett. 2010. PMID: 20206515
• β-1,3-Glucan/antisense oligonucleotide complex stabilized with phosphorothioation and its gene suppression.
  Mochizuki S, Sakurai K. Mochizuki S, et al. Bioorg Chem. 2010 Dec;38(6):260-4. doi: 10.1016/j.bioorg.2010.07.001. Epub 2010 Jul 31. Bioorg Chem. 2010. PMID: 20673953
• Antisense inhibition of human telomerase by phosphorothioate oligonucleotide-peptide conjugates.
  Diala I, Murao S, Fujii M. Diala I, et al. Nucleic Acids Symp Ser (Oxf). 2008;(52):679-80. doi: 10.1093/nass/nrn343. Nucleic Acids Symp Ser (Oxf). 2008. PMID: 18776562
• Phosphorothioates, essential components of therapeutic oligonucleotides.
  Eckstein F. Eckstein F. Nucleic Acid Ther. 2014 Dec;24(6):374-87. doi: 10.1089/nat.2014.0506. Nucleic Acid Ther. 2014. PMID: 25353652 Review.
• Antisense strategies for oncogene inactivation.
  Stein CA, Benimetskaya L, Mani S. Stein CA, et al. Semin Oncol. 2005 Dec;32(6):563-72. doi: 10.1053/j.seminoncol.2005.09.003. Semin Oncol. 2005. PMID: 16338422 Review.

Cited by

• Sequence-independent, site-specific incorporation of chemical modifications to generate light-activated plasmids.
  Chung K, Booth MJ. Chung K, et al. Chem Sci. 2023 Oct 13;14(44):12693-12706. doi: 10.1039/d3sc02761a. eCollection 2023 Nov 15. Chem Sci. 2023. PMID: 38020373 Free PMC article.
• DNAzymes: Expanding the Potential of Nucleic Acid Therapeutics.
  Larcher LM, Pitout IL, Keegan NP, Veedu RN, Fletcher S. Larcher LM, et al. Nucleic Acid Ther. 2023 Jun;33(3):178-192. doi: 10.1089/nat.2022.0066. Epub 2023 Apr 21. Nucleic Acid Ther. 2023. PMID: 37093127 Free PMC article. Review.
• Expanding Catch and Release DNA Decoy (CRDD) Technology with Pyrimidine Mimics.
  Kennelly SA, Moorthy R, Otero RS, Harki DA. Kennelly SA, et al. Chemistry. 2022 Oct 18;28(58):e202201355. doi: 10.1002/chem.202201355. Epub 2022 Aug 25. Chemistry. 2022. PMID: 35849314 Free PMC article.
• Light-control of cap methylation and mRNA translation via genetic code expansion of Ecm1.
  Reichert D, Mootz HD, Rentmeister A. Reichert D, et al. Chem Sci. 2021 Feb 8;12(12):4383-4388. doi: 10.1039/d1sc00159k. Chem Sci. 2021. PMID: 34163701 Free PMC article.
• Conditional gene knockdowns in sea urchins using caged morpholinos.
  Bardhan A, Deiters A, Ettensohn CA. Bardhan A, et al. Dev Biol. 2021 Jul;475:21-29. doi: 10.1016/j.ydbio.2021.02.014. Epub 2021 Mar 5. Dev Biol. 2021. PMID: 33684434 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley